2011 Publications

Allain P, Gaura V, Fasotti L, Chauviré V, Prundean A, Sherer-Gagou C, Bonneau D, Bachoud-Lévi A-C, Dubas F, Remy P, Le Gall D, Verny C. The neural substrates of script knowledge deficits as revealed by a PET study in Huntington’s disease. Neuropsychologia, 2011, May 30. [Epub ahead of print]

Ayache S-S, Adhab R, Brugières P, Ejzenbaum J-F, Authier F-J, Fénelon G, Lefaucheur J-P. A reappraisal of long-latency abdominal muscle reflexes in patients with propriospinal myoclonus. Mov Disord, 2011 Aug 1;26(9):1759-63. doi: 10.1002/mds.21

Bousser M-G, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K-M, Hennerici M-G, Mattle H-P, Rothwell P-M, de Cordoüe A, Fratacci M-D; PERFORM Study Investigators. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet, 2011, Jun 11; 377(9782):2013-22. Epub 2011 May 25

Cleret de Langavant L, Remy P, Trinkler I, McIntyre J, Dupoux E, Berthoz A, Bachoud-Lévi A-C. Behavioral and neural correlates of communication via pointing. PLoS One, 2011, Mar 15; 6(3):e17719.

De Diego-Balaguer, R., Fuentemilla, Ll, Rodriguez-Fornells, A. Brain dynamics sustaining rapid rule extraction from speech. Journal of Cognitive Neuroscience, 2011, Oct;23(10):3105-20. Epub 2011 Jan 26.

Drouot X, Moutereau S, Lefaucheur J-P, Palfi S, Covali-Noroc A, Margarit L, Stoïca-Herman M, Nguyen J-P, Cesaro P, D’Ortho M-P. Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD. Sleep Med, 2011, 12:936-7.

Dulin D, Cavezian C, Serrière C, Bachoud-Lévi A-C, Bartolomeo P, Chokron S. Colour, face, and visuospatial imagery abilities in low-vision individuals with visual field deficits. Q J Exp Psychol (Colchester). 2011 Oct;64(10):1955-70. Epub, 2011, Sep 26.

Fénelon G, Soulas T, Cleret de Langavant L, Trinkler I, Bachoud-Lévi A-C. 2011. Feeling of presence in Parkinson’s disease. J Neurol Neurosurg Psychiatry. Nov; 82(11):1219-24. Epub, 2011, May 7.

Freeman TB, Cicchetti F, Bachoud-Lévi A-C, Dunnett SB.Technical factors that influence neural transplant safety in Huntington’s disease. Exp Neurol, 2011 Jan, 227(1):1-9. Epub 2010 Sep 16.

Jacquemot, C, Dupoux, E & Bachoud-Lévi , A-C, Is the word length effect linked to subvocal rehearsal? Cortex, 2011, Apr;47(4):484-93.

López-Barroso D, de Diego-Balaguer R*, Cunillera, T. Camara E, Münte TF, Rodríguez-Fornells, A. Language learning under working memory constraints correlates with microstructural differences in the ventral language pathway. Cerebral Cortex, 2011 Dec;21(12):2742-50. Epub 2011 Apr 28.

Maison P, Saleh N, Bachoud-Lévi A-C. High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology, 2011 Feb 15; 76(7):675-6.

Mccrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G; NNIPPS STUDY GROUP. The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom. PLoS One, 2011;6:e24369.

Moroy A, Belliver F, Fénelon G. Olfactory reference syndrome: an unusual delusion in a patient with Parkinson’s disease. J Neuropsychiatry Clin Neurosci, 2012 Jun 1;24(3):10002.

Passeri E, Villa C, Couette M, Itti E, Brugieres P, Cesaro P, Gherardi RK, Bachoud-Lévi AC, Authier FJ.Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). J Inorg Biochem. 2011 Nov; 105(11):1457-63. Epub, 2011, Aug 22.

Payan CA, Viallet F, Landwehrmeyer B-G, Bonnet A-M, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph A-C, Leigh PN, Bensimon G; NNIPPS STUDY GROUP. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS—Parkinson Plus Scale. PLoS One,2011,6:e22293.

Robotham L, Sauter DA, Bachoud-Lévi A-C*, Trinkler I*. The impairment of emotion recognition in Huntington’s disease extends to positive emotions. Cortex., 2011, Jul-Aug;47(7):880-4. Epub 2011 Feb 23

Rolland Y, Vérin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph A-C, Bensimon G, Leigh PN; NNIPPS STUDY GROUP.A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry.,2011;82:1025-32.

Soulas T, Sultan S, Gurruchaga J-M, Palfi S, Fénelon G. Depression and Coping as Predictors of Change Following Deep Brain Stimulation in Parkinson Disease. World Neurosurg, 2011,75:525-32.

Thiriez C, Villafane G, Grapin F, Fénelon G, Remy P, Cesaro P. Can nicotine be used medicinally in Parkinson’s disease? Expert Rev Clin Pharmacol, 2011;4:429-43

Trinkler I, Cleret de Langavant L & Bachoud-Lévi A-C. Joint recognition-expression impairment of facial emotions in Huntington’s disease despite intact understanding of feelings. Cortex, 2011, Dec 16. [Epub ahead of print]

Vaccarino A, Sills T, Anderson KDE, Bachoud-Lévi A-C, Borowsky B, Craufurd D, et al. Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease, PLoS Curr, 2011, Jun 17;3:RRN1242

Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS; Huntington Study Group. Suicidal ideation in Huntington disease: the role of comorbidity. Psychiatry Res, 2011, Aug 15; 188(3):372-6. Epub 2011 May 24

Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lévi A-C, Tabrizi SJ, Di Donato S, Cattaneo E. Brain-derived neurotrophic factor in patients with Huntington’s disease. PLoS One. 2011;6(8):e22966. Epub, 2011, Aug 12